Pharmocann Global Ltd

TASE:PMCN-M 株式レポート

時価総額:₪3.8m

Pharmocann Global 配当金

配当金 基準チェック /06

Pharmocann Global does not have a record of paying a dividend.

主要情報

n/a

配当利回り

31.5%

バイバック利回り

総株主利回り31.5%
将来の配当利回りn/a
配当成長n/a
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
配当性向n/a

最近の配当金アップデート

更新なし

Recent updates

The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence

Mar 30
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence

Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?

Feb 04
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?

Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 31
Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come

Nov 26
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come

決済の安定と成長

配当データの取得

安定した配当: Insufficient data to determine if PMCN-M's dividends per share have been stable in the past.

増加する配当: Insufficient data to determine if PMCN-M's dividend payments have been increasing.


配当利回り対市場

Pharmocann Global 配当利回り対市場
PMCN-M 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (PMCN-M)n/a
市場下位25% (IL)2.4%
市場トップ25% (IL)6.5%
業界平均 (Pharmaceuticals)1.8%
アナリスト予想 (PMCN-M) (最長3年)n/a

注目すべき配当: Unable to evaluate PMCN-M's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

高配当: Unable to evaluate PMCN-M's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


株主への利益配当

収益カバレッジ: Insufficient data to calculate PMCN-M's payout ratio to determine if its dividend payments are covered by earnings.


株主配当金

キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as PMCN-M has not reported any payouts.


高配当企業の発掘